MGH Career Development Program in Substance Use and Addiction Medicine
Call for Applications
We are pleased to announce a new K12 Career Development Program in Substance Use and Addiction Medicine based at the Massachusetts General Hospital (MGH) and funded by the National Institute on Drug Abuse of the National Institutes of Health. The Program is a collaboration of the MGH Departments of Medicine and Psychiatry. Program Directors are A. Eden Evins (Psychiatry) and Nancy Rigotti (Medicine).
This program will provide salary, training and project support for a 2- to 5-year period of intensive mentored research training and career development for promising post-doctoral clinician-scientists who aim to establish independent research programs in patient-oriented substance use and addiction research. Research and training proposals are sought on a broad range of substance use and addiction medicine topics that include but are not limited to laboratory, clinical, or epidemiologic research into such topics as risk factors, neurobiologic mechanisms of addiction and recovery, treatment development, implementation of validated interventions, factors associated with recovery, and policy.
The program will offer a multidisciplinary clinical research training program based at MGH and Harvard Medical School. It aims to provide scholars with a concentrated research experience, mentorship, and advanced training to prepare them for leadership in addiction medicine through independent research careers in academics or industry or influential positions in government. The program will support (1) advanced education and training in research methods relevant to a scholar’s area of interest, and (2) a mentored research experience in the addiction research programs at MGH or affiliated hospitals and institutions. Awards will generally be made for 2-3 years, contingent on the scholar’s progress. However, extension for a longer period of support up to 5 years, may be allowed depending on a candidate’s specific situation and needs.
Funding includes an annual stipend of $80,000 for 75-100% effort and up to $42,000 annually in allowable research and training costs that may be applied to travel to scientific meetings, research project costs, and tuition expenses with approval of the mentor and program leaders.
Eligible applicants will have completed doctoral-level training in a clinical discipline (MD, PhD or equivalent). Additional research training prior to this program is preferred but not required. Appropriate students can learn quantitative and analytic skills by attending the 10-week Program in Clinical Effectiveness of Harvard’s TH Chan School of Public Health (HSPH) in their first summer. Admission to that program requires completing separate application to HSPH.
Applications are now being accepted for scholars to start the program in June or July 2018.
Final due date for applications is February 23, 2018. We strongly recommend that applications be submitted by February 16, 2018. Submissions received by 2/16 will be read for omissions or clarifications required prior to the 2/23 deadline.
Applications received after 5pm EST 2/23/18 and incomplete applications received on 2/23/18 will not be considered. There will be no deadline extensions for technical difficulties interfering with application submission on 2/23/18.
A letter of intent is requested (not required) by January 12, 2018. Application instructions can be found here. Applications must be accompanied by letters of recommendation, one from a clinical training program director and one from a current or recent research mentor. A letter of support from a proposed K12 program mentor is also required. A list of mentors can be found here.